Relationships of Microbiome Markers With Extraintestinal, Psychological Distress and Gastrointestinal Symptoms, and Quality of Life in Women With Irritable Bowel Syndrome

Overview

Journal J Clin Gastroenterol

Specialty Gastroenterology

Date 2018 Aug 28

PMID 30148765

Citations 31

Authors

Emily B Hollister

Kevin C Cain

Robert J Shulman

Monica E Jarrett

Robert L Burr

Cynthia Ko

Jasmine Zia

Claire J Han

Margaret M Heitkemper

Affiliations

Soon will be listed here.

Abstract

Introduction: Altered microbial diversity has been associated with gastrointestinal (GI) symptoms in persons with irritable bowel syndrome (IBS). Less is known about the relationship of microbiome with extraintestinal pain and psychological distress symptoms and quality of life (QOL) in persons with IBS. We aimed to evaluate the relationship of fecal microbiota to GI symptoms, stool consistency, psychological distress, extraintestinal pain, and QOL in participants meeting Rome III criteria for IBS.

Methods: Seventy-six women completed a 28-day diary that included GI, stool consistency, psychological distress, and extraintestinal pain ratings. Participants completed the IBS-Specific Quality of Life questionnaire. Stool samples were collected and analyzed by 16S rRNA gene sequencing. Principal component analysis was performed and the first 2 components (PC1, PC2) were used to test relationships among bacterial families and clinical measures.

Results: Participants were categorized as IBS constipation (n=22), IBS diarrhea (n=39), IBS mixed (n=13), and IBS unsubtyped (n=2). There was a significant group effect for the Firmicutes to Bacteroidetes ratio and PC1. Lower microbial diversity and richness were associated with increased urgency and extraintestinal pain, worse QOL, and looser stools. Lower extraintestinal pain was associated with increased Rikenellaceae, Christensenellaceae, Dehalobabacteriaceae, Oscillospiraceae, Mogibacteriaceae, Ruminococcaceae, Sutterellaceae, Desulfovibrionaceae, and Erysipelotrichaceae abundances. QOL was positively associated with many of these same bacterial families. Higher Firmicutes to Bacteroidetes ratio was positively associated with loose stools. There were no statistically significant relationships between daily psychological distress or abdominal pain and bacterial families.

Conclusions: Stool microbial diversity and composition are linked to daily extraintestinal symptoms, stool consistency, and QOL in women with IBS.

Citing Articles

Meta-analysis of gut microbiota alterations in patients with irritable bowel syndrome.

Li X, Li X, Xiao H, Xu J, He J, Xiao C Front Microbiol. 2025; 15():1492349.

PMID: 39777150 PMC: 11703917. DOI: 10.3389/fmicb.2024.1492349.

Chronic pain and complex regional pain syndrome are associated with alterations to the intestinal microbiota in both humans and mice. An observational cross-sectional study.

Crock L, Rodgers R, Huck N, Schriefer L, Lawrence D, Wang L Neurobiol Pain. 2024; 16:100173.

PMID: 39670171 PMC: 11636187. DOI: 10.1016/j.ynpai.2024.100173.

The Efficacy of Probiotics Supplementation on the Quality of Life of Patients with Gastrointestinal Disease: A Systematic Review of Clinical Studies.

Moludi J, Saber A, Zozani M, Moradi S, Azamian Y, Hajiahmadi S Prev Nutr Food Sci. 2024; 29(3):237-255.

PMID: 39371511 PMC: 11450280. DOI: 10.3746/pnf.2024.29.3.237.

Weight, habitual fibre intake, and microbiome composition predict tolerance to fructan supplementation.

Letourneau J, Neubert B, Dayal D, Carrion V, Durand H, Dallow E Int J Food Sci Nutr. 2024; 75(6):571-581.

PMID: 38982571 PMC: 11491164. DOI: 10.1080/09637486.2024.2372590.

Disturbance of the human gut microbiota in patients with Myotonic Dystrophy type 1.

Mahdavi M, Prevost K, Balthazar P, Hus I, Duchesne E, Dumont N Comput Struct Biotechnol J. 2024; 23:2097-2108.

PMID: 38803516 PMC: 11128782. DOI: 10.1016/j.csbj.2024.05.009.

References

Parthasarathy G, Chen J, Chen X, Chia N, OConnor H, Wolf P . Relationship Between Microbiota of the Colonic Mucosa vs Feces and Symptoms, Colonic Transit, and Methane Production in Female Patients With Chronic Constipation. Gastroenterology. 2015; 150(2):367-79.e1. PMC: 4727996. DOI: 10.1053/j.gastro.2015.10.005. View

Di Stefano M, Mengoli C, Bergonzi M, Klersy C, Pagani E, Miceli E . Breath Methane Excretion Is not An Accurate Marker of Colonic Methane Production in Irritable Bowel Syndrome. Am J Gastroenterol. 2015; 110(6):891-8. DOI: 10.1038/ajg.2015.47. View

Mujagic Z, Leue C, Vork L, Lousberg R, Jonkers D, Keszthelyi D . The Experience Sampling Method--a new digital tool for momentary symptom assessment in IBS: an exploratory study. Neurogastroenterol Motil. 2015; 27(9):1295-302. DOI: 10.1111/nmo.12624. View

Mitra D, Davis K, Baran R . All-cause health care charges among managed care patients with constipation and comorbid irritable bowel syndrome. Postgrad Med. 2011; 123(3):122-32. DOI: 10.3810/pgm.2011.05.2290. View

Roager H, Hansen L, Bahl M, Frandsen H, Carvalho V, Gobel R . Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut. Nat Microbiol. 2016; 1(9):16093. DOI: 10.1038/nmicrobiol.2016.93. View

Li G, Yang M, Jin Y, Li Y, Qian W, Xiong H . Involvement of shared mucosal-associated microbiota in the duodenum and rectum in diarrhea-predominant irritable bowel syndrome. J Gastroenterol Hepatol. 2017; 33(6):1220-1226. DOI: 10.1111/jgh.14059. View

Kaakoush N . Insights into the Role of Erysipelotrichaceae in the Human Host. Front Cell Infect Microbiol. 2015; 5:84. PMC: 4653637. DOI: 10.3389/fcimb.2015.00084. View

Chen L, Wilson J, Koenigsknecht M, Chou W, Montgomery S, Truax A . NLRP12 attenuates colon inflammation by maintaining colonic microbial diversity and promoting protective commensal bacterial growth. Nat Immunol. 2017; 18(5):541-551. PMC: 5395345. DOI: 10.1038/ni.3690. View

Tap J, Derrien M, Tornblom H, Brazeilles R, Cools-Portier S, Dore J . Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome. Gastroenterology. 2016; 152(1):111-123.e8. DOI: 10.1053/j.gastro.2016.09.049. View

10.

Aagaard K, Petrosino J, Keitel W, Watson M, Katancik J, Garcia N . The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters. FASEB J. 2012; 27(3):1012-22. PMC: 3574278. DOI: 10.1096/fj.12-220806. View

11.

Kim J, Lin E, Pimentel M . Biomarkers of Irritable Bowel Syndrome. J Neurogastroenterol Motil. 2016; 23(1):20-26. PMC: 5216630. DOI: 10.5056/jnm16135. View

12.

Whorwell P, Altringer L, Morel J, Bond Y, Charbonneau D, OMahony L . Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol. 2006; 101(7):1581-90. DOI: 10.1111/j.1572-0241.2006.00734.x. View

13.

Shulman R, Jarrett M, Cain K, Broussard E, Heitkemper M . Associations among gut permeability, inflammatory markers, and symptoms in patients with irritable bowel syndrome. J Gastroenterol. 2014; 49(11):1467-76. PMC: 4102674. DOI: 10.1007/s00535-013-0919-6. View

14.

Cox L, Cho I, Young S, Anderson W, Waters B, Hung S . The nonfermentable dietary fiber hydroxypropyl methylcellulose modulates intestinal microbiota. FASEB J. 2012; 27(2):692-702. PMC: 3545536. DOI: 10.1096/fj.12-219477. View

15.

Jarrett M, Cain K, Barney P, Burr R, Naliboff B, Shulman R . Balance of Autonomic Nervous System Predicts Who Benefits from a Self-management Intervention Program for Irritable Bowel Syndrome. J Neurogastroenterol Motil. 2015; 22(1):102-11. PMC: 4699727. DOI: 10.5056/jnm15067. View

16.

Pozuelo M, Panda S, Santiago A, Mendez S, Accarino A, Santos J . Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome. Sci Rep. 2015; 5:12693. PMC: 4523847. DOI: 10.1038/srep12693. View

17.

Longstreth G, Wolde-Tsadik G . Irritable bowel-type symptoms in HMO examinees. Prevalence, demographics, and clinical correlates. Dig Dis Sci. 1993; 38(9):1581-9. DOI: 10.1007/BF01303163. View

18.

Messaoudi M, Lalonde R, Violle N, Javelot H, Desor D, Nejdi A . Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr. 2010; 105(5):755-64. DOI: 10.1017/S0007114510004319. View

19.

Jarrett M, Cain K, Burr R, Hertig V, Rosen S, Heitkemper M . Comprehensive self-management for irritable bowel syndrome: randomized trial of in-person vs. combined in-person and telephone sessions. Am J Gastroenterol. 2009; 104(12):3004-14. PMC: 2804069. DOI: 10.1038/ajg.2009.479. View

20.

Rajilic-Stojanovic M, Biagi E, Heilig H, Kajander K, Kekkonen R, Tims S . Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology. 2011; 141(5):1792-801. DOI: 10.1053/j.gastro.2011.07.043. View